Translate Bio’s mRNA candidate produces mixed results in CF trial
The drug candidate is designed to target the disease’s underlying cause. Credit: lisichik from Pixabay.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more